Corey A. Scipione

Corey A. Scipione

Auto-generated profile, based on publicly available information

Corey A. Scipione

Peter Munk Cardiac Centre Research Institute, University Health Network, Toronto, ON, Canada (M.G.A., H.M.I., S.J.H., S.Z.P., M.R., E.A.-C., C.A.S., C.K.P., S.A.D., S.E., C.S.R., M.I.C.).

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2016 in Circulation
Verified
Journal Article
Closed access
PDF file
FVFleur M. van der Valk
Fleur M. van der Valk
SBSiroon Bekkering
Siroon Bekkering
JKJeffrey Kroon
Jeffrey Kroon
CYCalvin Yeang
Calvin Yeang
Jan Van den BosscheJan Van den Bossche
Jan Van den Bossche
ESErik S.G. Stroes
Erik S.G. Stroes
Background: Elevated lipoprotein(a) [Lp(a)] is a prevalent, independent cardiovascular risk factor, but the underlying mechanisms responsible for its pathogenicity are poorly defined. Because Lp(a) is the prominent carrier of proinflammatory oxidized phospholipids (OxPLs), part of its atherothrombosis might be mediated through this pathway. Methods: In vivo imaging techniques including magnetic resonance imaging, 18 F-fluorodeoxyglucose uptake positron emission tomography/computed tomography and single-photon emission computed tomography/computed tomography were used to measure subsequently atherosclerotic burden, arterial wall inflammation, and monocyte trafficking to the arterial wall. Ex vivo analysis of monocytes was performed with fluorescence-activated cell sorter analysis, inflammatory stimulation assays, and transendothelial migration assays. In vitro studies of the pathophysiology of Lp(a) on monocytes were performed with an in vitro model for trained immunity. Results: We show that subjects with elevated Lp(a) (108 mg/dL [50–195 mg/dL]; n=30) have increased arterial inflammation and enhanced peripheral blood mononuclear cells trafficking to the arterial wall compared with subjects with normal Lp(a) (7 mg/dL [2–28 mg/dL]; n=30). In addition, monocytes isolated from subjects with elevated Lp(a) remain in a long-lasting primed state, as evidenced by an increased capacity to transmigrate and produce proinflammatory cytokines on stimulation (n=15). In vitro studies show that Lp(a) contains OxPL and augments the proinflammatory response in monocytes derived from healthy control subjects (n=6). This effect was markedly attenuated by inactivating OxPL on Lp(a) or removing OxPL on apolipoprotein(a). Conclusions: These findings demonstrate that Lp(a) induces monocyte trafficking to the arterial wall and mediates proinflammatory responses through its OxPL content. These findings provide a novel mechanism by which Lp(a) mediates cardiovascular disease. Clinical Trial Registration: URL: http://www.trialregister.nl . Unique identifier: NTR5006 (VIPER Study).

25 August 2015 in Circulation
Verified
Journal Article
Closed access
RBRihab Bouchareb
Rihab Bouchareb
AMAblajan Mahmut
Ablajan Mahmut
MNMohamed Jalloul Nsaibia
Mohamed Jalloul Nsaibia
MBMarie-Chloé Boulanger
Marie-Chloé Boulanger
ADAbdellaziz Dahou
Abdellaziz Dahou
PMPatrick Mathieu
Patrick Mathieu
Background—: Mendelian randomization studies have highlighted that lipoprotein(a) [Lp(a)] was associated with calcific aortic valve disease (CAVD). Lp(a) transports oxidized phospholipids with a high content in lysophosphatidylcholine. Autotaxin (ATX) transforms lysophosphatidylcholine into lysophosphatidic acid. We hypothesized that ATX-lysophosphatidic acid could promote inflammation/mineralization of the aortic valve. Methods and Results—: We have documented the expression of ATX in control and mineralized aortic valves. By using different approaches, we have also investigated the role of ATX-lysophosphatidic acid in the mineralization of isolated valve interstitial cells and in a mouse model of CAVD. Enzyme-specific ATX activity was elevated by 60% in mineralized aortic valves in comparison with control valves. Immunohistochemistry studies showed a high level of ATX in mineralized aortic valves, which colocalized with oxidized phospholipids and apolipoprotein(a). We detected a high level of ATX activity in the Lp(a) fraction in circulation. Interaction between ATX and Lp(a) was confirmed by in situ proximity ligation assay. Moreover, we documented that valve interstitial cells also expressed ATX in CAVD. We showed that ATX-lysophosphatidic acid promotes the mineralization of the aortic valve through a nuclear factor κB/interleukin 6/bone morphogenetic protein pathway. In LDLR –/– /ApoB 100/100 /IGFII mice, ATX is overexpressed and lysophosphatidic acid promotes a strong deposition of hydroxyapatite of calcium in aortic valve leaflets and accelerates the development of CAVD. Conclusions—: ATX is transported in the aortic valve by Lp(a) and is also secreted by valve interstitial cells. ATX-lysophosphatidic acid promotes inflammation and mineralization of the aortic valve and thus could represent a novel therapeutic target in CAVD.

1 October 2013 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
GLGregor Leibundgut
Gregor Leibundgut
CSCorey Scipione
Corey Scipione
HYHuiyong Yin
Huiyong Yin
MSMatthias Schneider
Matthias Schneider
MBMichael B. Boffa
Michael B. Boffa
STSotirios Tsimikas
Sotirios Tsimikas
Gregor Leibundgut, Corey Scipione, Huiyong Yin, Matthias Schneider, Michael B. Boffa, Simone Green, Xiaohong Yang, Edward Dennis, Joseph L. Witztum, Marlys L. Koschinsky, Sotirios Tsimikas

1 May 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
RRRocco Romagnuolo
Rocco Romagnuolo
CSCorey A. Scipione
Corey A. Scipione
MBMichael B. Boffa
Michael B. Boffa
SMSantica M. Marcovina
Santica M. Marcovina
NSNabil G. Seidah
Nabil G. Seidah
MKMarlys L. Koschinsky
Marlys L. Koschinsky
Elevated levels of lipoprotein(a) (Lp(a)) have been identified as an independent risk factor for coronary heart disease. Plasma Lp(a) levels are reduced by monoclonal antibodies targeting proprotein convertase subtilisin/kexin type 9 (PCSK9). However, the mechanism of Lp(a) catabolism in vivo and the role of PCSK9 in this process are unknown. We report that Lp(a) internalization by hepatic HepG2 cells and primary human fibroblasts was effectively reduced by PCSK9. Overexpression of the low density lipoprotein (LDL) receptor (LDLR) in HepG2 cells dramatically increased the internalization of Lp(a). Internalization of Lp(a) was markedly reduced following treatment of HepG2 cells with a function-blocking monoclonal antibody against the LDLR or the use of primary human fibroblasts from an individual with familial hypercholesterolemia; in both cases, Lp(a) internalization was not affected by PCSK9. Optimal Lp(a) internalization in both hepatic and primary human fibroblasts was dependent on the LDL rather than the apolipoprotein(a) component of Lp(a). Lp(a) internalization was also dependent on clathrin-coated pits, and Lp(a) was targeted for lysosomal and not proteasomal degradation. Our data provide strong evidence that the LDLR plays a role in Lp(a) catabolism and that this process can be modulated by PCSK9. These results provide a direct mechanism underlying the therapeutic potential of PCSK9 in effectively lowering Lp(a) levels.

1 December 2015 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
CSCorey A. Scipione
Corey A. Scipione
SSSera E. Sayegh
Sera E. Sayegh
RRRocco Romagnuolo
Rocco Romagnuolo
STSotirios Tsimikas
Sotirios Tsimikas
SMSantica M. Marcovina
Santica M. Marcovina
MKMarlys L. Koschinsky
Marlys L. Koschinsky
Elevated lipoprotein(a) (Lp(a)) levels are a causal risk factor for coronary heart disease. Accumulating evidence suggests that Lp(a) can stimulate cellular inflammatory responses through the kringle-containing apolipoprotein(a) (apo(a)) component. Here, we report that recombinant apo(a) containing 17 kringle-IV domains (17K) elicits a dose-dependent increase in IL-8 mRNA and protein expression in THP-1 and U937 macrophages. This effect was blunted by mutation of the lysine binding site in apo(a) KIV10, which results in the loss of oxidized phospholipid (oxPL) on apo(a). Trypsin-digested 17K had the same stimulatory effect on IL-8 expression as intact apo(a) while enzymatic removal of oxPL from apo(a) significantly blunted this effect. Using siRNA to assess candidate receptors, we found that CD36 and TLR2 may play roles in apo(a)-mediated IL-8 stimulation. Downstream of these receptors, inhibitors of MAP kinases JNK and ERK1/2 abolished the effect of apo(a) on IL-8 gene expression. To assess roles of downstream transcription factors, luciferase reporter gene experiments were conducted using an IL-8 promoter fragment. Apo(a) induced expression of this reporter construct was eliminated by mutation of IL-8 promoter binding sites for either NF-κB or AP-1. Our results provide a mechanistic link between oxPL modification of apo(a) and stimulation of proinflammatory intracellular signaling pathways.

1 April 2012 in JACC
Verified
Journal Article
Closed access
GLGregor Leibundgut
Gregor Leibundgut
KAKiyohito Arai
Kiyohito Arai
AOAlexina Orsoni
Alexina Orsoni
HYHuiyong Yin
Huiyong Yin
CSCorey Scipione
Corey Scipione
STSotirios Tsimikas
Sotirios Tsimikas